Get started
Author

Fuben Liao

ORCID: 0009-0001-5329-1628
Observed ORCID: 0009-0001-5329-1628
OpenAlex ID: A5027533301
A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis
2024 · Yimin Dong, Honglei Kang, et al. · Cell Metabolism · 102
Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment
2022 · Songjiang He, Shi Zhang, et al. · Frontiers in Oncology · 17
Tumor-Educated Platelets Facilitate Thrombus Formation Through Migration
2022 · Zheming Liu, Jing Wang, et al. · Frontiers in Oncology · 10
TRAF1 promotes osteoclastogenesis by enhancing metabolic adaptation to oxidative phosphorylation in an AKT-dependent manner
2025 · Honglei Kang, Renpeng Peng, et al. · Molecular Therapy · 8
Uncovering BTB and CNC Homology1 (BACH1) as a Novel Cancer Therapeutic Target
2022 · Zheming Liu, Jing Wang, et al. · Frontiers in Genetics · 8
The role of FOXK2 – FBXO32 in breast cancer tumorigenesis: Insights into ribosome‐associated pathways
2024 · Fuben Liao, Jinjin Zhu, et al. · Thoracic Cancer · 2
PANoptosis-based molecular subtype and prognostic model predict survival and immune landscape in esophageal cancer
2024 · Zheming Liu, Jiahui Liu, et al. · Clinical Cancer Bulletin · 2
FOSL1 promotes homologous recombination repair and camptothecin resistance via TCOF1-mediated ribosome biogenesis in non-small cell lung cancer
2026 · Chunmei Hao, Luojun Chen, et al. · Translational Oncology · 1
Metabolic Mediators Linking Type 1 Diabetes Mellitus to Osteoporosis
2025 · Yuxin Chu, Jinjin Zhu, et al. · Archives of Medical Science · 1
PDF
Sex Hormone-Binding Globulin Mediates Different Effect on Osteoporosis in Men and Women
2024 · Munan Guo, Fengxia Zhang, et al. · SSRN Electronic Journal
Works count: 10
Citation count: 151
H-index: 5
I10-index: 3
Year
Topic
Type